Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

May 06, 2021

BUY
$59.34 - $66.74 $1.34 Million - $1.5 Million
22,528 New
22,528 $1.42 Million
Q4 2020

Feb 09, 2021

SELL
$57.74 - $65.43 $2.87 Million - $3.25 Million
-49,743 Closed
0 $0
Q3 2020

Nov 09, 2020

SELL
$57.43 - $63.64 $2.54 Million - $2.81 Million
-44,193 Reduced 47.05%
49,743 $3 Million
Q2 2020

Aug 04, 2020

BUY
$54.82 - $64.09 $3.25 Million - $3.8 Million
59,358 Added 171.66%
93,936 $5.52 Million
Q1 2020

May 06, 2020

SELL
$46.4 - $67.43 $998,017 - $1.45 Million
-21,509 Reduced 38.35%
34,578 $1.93 Million
Q4 2019

Feb 11, 2020

BUY
$49.21 - $64.19 $2.23 Million - $2.91 Million
45,309 Added 420.38%
56,087 $3.6 Million
Q3 2019

Nov 07, 2019

SELL
$42.77 - $50.71 $1.4 Million - $1.67 Million
-32,841 Reduced 75.29%
10,778 $547,000
Q2 2019

Jul 25, 2019

BUY
$44.62 - $49.34 $1.06 Million - $1.18 Million
23,844 Added 120.58%
43,619 $1.98 Million
Q1 2019

Apr 15, 2019

SELL
$45.12 - $53.8 $776,605 - $926,005
-17,212 Reduced 46.54%
19,775 $943,000
Q4 2018

Feb 12, 2019

BUY
$48.76 - $63.23 $674,984 - $875,292
13,843 Added 59.81%
36,987 $1.92 Million
Q3 2018

Nov 14, 2018

SELL
$55.19 - $62.25 $265,243 - $299,173
-4,806 Reduced 17.19%
23,144 $1.44 Million
Q2 2018

Aug 07, 2018

SELL
$50.53 - $62.98 $199,644 - $248,833
-3,951 Reduced 12.39%
27,950 $1.55 Million
Q1 2018

May 04, 2018

SELL
$59.92 - $68.98 $329,799 - $379,665
-5,504 Reduced 14.71%
31,901 $2.02 Million
Q4 2017

Feb 01, 2018

SELL
$59.94 - $65.35 $103,756 - $113,120
-1,731 Reduced 4.42%
37,405 $2.29 Million
Q3 2017

Oct 18, 2017

BUY
$55.23 - $63.74 $2.16 Million - $2.49 Million
39,136
39,136 $2.5 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $123B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Quantitative Systematic Strategies LLC Portfolio

Follow Quantitative Systematic Strategies LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Quantitative Systematic Strategies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Quantitative Systematic Strategies LLC with notifications on news.